Clinical Prophylaxis
Dr. Rungrote Natesirinilkul had spent two years training in hemostasis at the Hospital for Sick Children at the University of Toronto, prior to accepting his position as an assistant professor at Chiang Mai University in Thailand. He actively attends national, regional and international meetings on hemostasis as well as hemophilia and has been exposed to knowledge on patient care in relation to prophylaxis and the particular barriers faced in Southeast Asia.
NatesirinilkulR, Charoenkwan P, ChuansumritA, PruksakornD, VisrutaratnaP, JutavijittumR,et al. Treatment of severe hemophilia A with high-titer inhibitorby plasma exchange and continuous infusion of recombinantfactor VIII: a case report.Thai J Hematol Transfus Med 2012;22:41-9.
Natesirinilkul R.Evolution in hemophilia treatment. Chiang Mai Medical Journal 2015;51:151-6.
Natesirinilkul R, Charoenkwan P, Ruangrongrat R, Chittawatanarat K, Chuansumrit A, Jutavijittum R, et al. Abdominal Compartment Syndrome in a Patient with Hemophilia A with a High Titer Inhibitor after a Minor Trauma. J Trauma Treat 2016;5:300.
Chuansumrit A, Sosothikul D, Natesirinilkul R, Lektrakul Y, Charoonruangrit U; Factor VIII Study Group. Efficacy and safety of low-dose prophylaxis of highly purified plasma-derived factor VIII concentrate produced by the National Blood Centre, Thai Red Cross Society.Haemophilia2018;24:e387-90.